Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satoshi Endo

Showing results (381-390 of 395) with videos related to

Pageof 40
Sort By:
Bioorganic & Medicinal Chemistry|August 23, 2011
Discovery, synthesis, and structure-activity relationship of 6-aminomethyl-7,8-dihydronaphthalenes as human melanin-concentrating hormone receptor 1 antagonistsMakoto Kamata, Toshiro Yamashita, Toshihiro Imaeda, et al.
Journal of Medicinal Chemistry|August 2, 2018
Discovery of 3-Benzyl-1-( trans-4-((5-cyanopyridin-2-yl)amino)cyclohexyl)-1-arylurea Derivatives as Novel and Selective Cyclin-Dependent Kinase 12 (CDK12) InhibitorsMasahiro Ito, Toshio Tanaka, Akinori Toita, et al.
Plant & Cell Physiology|April 29, 2009
KORRIGAN1 and its aspen homolog PttCel9A1 decrease cellulose crystallinity in Arabidopsis stemsJunko Takahashi, Ulla J Rudsander, Mattias Hedenström, et al.
Lung Cancer (Amsterdam, Netherlands)|April 28, 2024
Mirtazapine plus granisetron and dexamethasone for carboplatin-induced nausea and vomiting in patients with thoracic cancers: A prospective multicenter phase II trialHirotoshi Iihara, Masamichi Iwai, Ryo Morita, et al.
Environmental Science & Technology|July 20, 2022
Correction to "Sorption and Mobility of Charged Organic Compounds: How to Confront and Overcome Limitations in Their Assessment"Gabriel Sigmund, Hans Peter H Arp, Benedikt M Aumeier, et al.
Environmental Science & Technology|March 30, 2022
Sorption and Mobility of Charged Organic Compounds: How to Confront and Overcome Limitations in Their AssessmentGabriel Sigmund, Hans Peter H Arp, Benedikt M Aumeier, et al.
Cancer Immunology, Immunotherapy : CII|December 31, 2024
Correction: Risk factors indicating immune-related adverse events with combination chemotherapy with immune checkpoint inhibitors and platinum agents in patients with non-small cell lung cancer: a multicenter retrospective studyAiri Fujimoto, Yoshimichi Koutake, Daisuke Hisamatsu, et al.
Cancer Immunology, Immunotherapy : CII|February 28, 2023
Risk factors indicating immune-related adverse events with combination chemotherapy with immune checkpoint inhibitors and platinum agents in patients with non-small cell lung cancer: a multicenter retrospective studyAiri Fujimoto, Yoshimichi Koutake, Daisuke Hisamatsu, et al.
Oncology|February 8, 2022
Metformin-Induced Heat Shock Protein Family A Member 6 Is a Promising Biomarker of Esophageal Squamous Cell CarcinomaNobufumi Sekino, Masayuki Kano, Sohei Kobayashi, et al.
Thoracic Cancer|June 30, 2025
Significance of Platinum-Based Chemotherapy With Programmed Death-1 Blockade in Limited Disease Small Cell Lung Cancer: A Retrospective StudyAyako Shiono, Hisao Imai, Kyoichi Kaira, et al.
Pageof 40

Showing results (381-390 of 395) with videos related to

Sort By:
Pageof 40
Bioorganic & Medicinal Chemistry|August 23, 2011
Discovery, synthesis, and structure-activity relationship of 6-aminomethyl-7,8-dihydronaphthalenes as human melanin-concentrating hormone receptor 1 antagonistsMakoto Kamata, Toshiro Yamashita, Toshihiro Imaeda, et al.
Journal of Medicinal Chemistry|August 2, 2018
Discovery of 3-Benzyl-1-( trans-4-((5-cyanopyridin-2-yl)amino)cyclohexyl)-1-arylurea Derivatives as Novel and Selective Cyclin-Dependent Kinase 12 (CDK12) InhibitorsMasahiro Ito, Toshio Tanaka, Akinori Toita, et al.
Plant & Cell Physiology|April 29, 2009
KORRIGAN1 and its aspen homolog PttCel9A1 decrease cellulose crystallinity in Arabidopsis stemsJunko Takahashi, Ulla J Rudsander, Mattias Hedenström, et al.
Lung Cancer (Amsterdam, Netherlands)|April 28, 2024
Mirtazapine plus granisetron and dexamethasone for carboplatin-induced nausea and vomiting in patients with thoracic cancers: A prospective multicenter phase II trialHirotoshi Iihara, Masamichi Iwai, Ryo Morita, et al.
Environmental Science & Technology|July 20, 2022
Correction to "Sorption and Mobility of Charged Organic Compounds: How to Confront and Overcome Limitations in Their Assessment"Gabriel Sigmund, Hans Peter H Arp, Benedikt M Aumeier, et al.
Environmental Science & Technology|March 30, 2022
Sorption and Mobility of Charged Organic Compounds: How to Confront and Overcome Limitations in Their AssessmentGabriel Sigmund, Hans Peter H Arp, Benedikt M Aumeier, et al.
Cancer Immunology, Immunotherapy : CII|December 31, 2024
Correction: Risk factors indicating immune-related adverse events with combination chemotherapy with immune checkpoint inhibitors and platinum agents in patients with non-small cell lung cancer: a multicenter retrospective studyAiri Fujimoto, Yoshimichi Koutake, Daisuke Hisamatsu, et al.
Cancer Immunology, Immunotherapy : CII|February 28, 2023
Risk factors indicating immune-related adverse events with combination chemotherapy with immune checkpoint inhibitors and platinum agents in patients with non-small cell lung cancer: a multicenter retrospective studyAiri Fujimoto, Yoshimichi Koutake, Daisuke Hisamatsu, et al.
Oncology|February 8, 2022
Metformin-Induced Heat Shock Protein Family A Member 6 Is a Promising Biomarker of Esophageal Squamous Cell CarcinomaNobufumi Sekino, Masayuki Kano, Sohei Kobayashi, et al.
Thoracic Cancer|June 30, 2025
Significance of Platinum-Based Chemotherapy With Programmed Death-1 Blockade in Limited Disease Small Cell Lung Cancer: A Retrospective StudyAyako Shiono, Hisao Imai, Kyoichi Kaira, et al.
Pageof 40